UK pharma giants pledge £430m investment in France after Macron charm offensive
President Macron’s investments were unveiled as part of the “Choose France” investment summit held at the Palace of Versailles yesterday.More...
archivePharmaceuticals
South Rampart Pharma Expands Global Patent Portfolio with EU Approval for FDA Fast-Tracked SRP-001 for Pain
South Rampart's Global Intellectual Property Portfolio Now Includes Patents in Key Markets: United States, Europe, Greater China, India, Japan, S....
American Airlines, Moderna, Ford, Citigroup, Apple, and More Stock Market Movers
American Airlines (ticker: AAL) slid 5.7% after cutting guidance, prompted by higher labor costs following its pay agreement with pilots...
First Republic, FedEx, Sarepta, XPeng, RingCentral, and More Stock Market Movers
Stocks closed lower Friday, as investors grappled with continued banking troubles ahead of next week’s Federal Reserve meeting. First Republic...
New research reveals chronic insomnia disorder costs UK economy up to £34billion per year
First of its kind research indicates that if chronic insomnia disorder (CID) was treated effectively and comprehensively across the working age population, it could increase the GDP in the UK by as much as £34billion per year1* Report suggests that working days lost to CID result in an overall cost to UK GDP of 1.31% in lost productivity per year1 Report estimates the total wellbeing costs of insomnia in the UK could be close to £17.7billion1* LONDON, March 17, 2023 /PRNewswire/ -- On World Sleep Day 2023, Idorsia UK calls...
U.K. stocks drop for first time in four days
Published: Feb. 17, 2023 at 12:01 p.m. ET U.K. stocks finished lower Friday, with the FTSE 100 Index FTSE 100...
Secura Bio, Inc. Receives Orphan Drug Designation in Europe for Duvelisib for the Treatment of Patients with Peripheral T-cell Lymphoma
SUMMERLIN, Nev., Jan. 9, 2023 /PRNewswire/ -- Secura Bio, Inc. (Secura Bio) - (www.securabio.com), an integrated pharmaceutical company dedicated to the...
US Capital Engaged by Canadian Health Science Pioneer
San Francisco, California, USA, Dec. 30, 2022 (GLOBE NEWSWIRE) -- US Capital has been engaged by Andira Pharmaceuticals (“Andira” or the “Company”) as...
